These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12544374)

  • 1. Improvement of sleep and pituitary-adrenal inhibition after subchronic intranasal vasopressin treatment in elderly humans.
    Perras B; Wagner U; Born J; Fehm HL
    J Clin Psychopharmacol; 2003 Feb; 23(1):35-44. PubMed ID: 12544374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin.
    Perras B; Pannenborg H; Marshall L; Pietrowsky R; Born J; Lorenz Fehm H
    J Clin Psychopharmacol; 1999 Feb; 19(1):28-36. PubMed ID: 9934940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans.
    Perras B; Marshall L; Köhler G; Born J; Fehm HL
    Psychoneuroendocrinology; 1999 Oct; 24(7):743-57. PubMed ID: 10451909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans.
    Held K; Antonijevic IA; Künzel H; Uhr M; Wetter TC; Golly IC; Steiger A; Murck H
    Pharmacopsychiatry; 2002 Jul; 35(4):135-43. PubMed ID: 12163983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal insulin decreases circulating cortisol concentrations during early sleep in elderly humans.
    Thienel M; Wilhelm I; Benedict C; Born J; Hallschmid M
    Neurobiol Aging; 2017 Jun; 54():170-174. PubMed ID: 28385552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal atrial natriuretic peptide acts as central nervous inhibitor of the hypothalamo-pituitary-adrenal stress system in humans.
    Perras B; Schultes B; Behn B; Dodt C; Born J; Fehm HL
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4642-8. PubMed ID: 15356075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
    Schmid DA; Brunner H; Lauer CJ; Uhr M; Yassouridis A; Holsboer F; Friess E
    J Psychiatr Res; 2008 Oct; 42(12):991-9. PubMed ID: 18226817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.
    Pietrowsky R; Strüben C; Mölle M; Fehm HL; Born J
    Biol Psychiatry; 1996 Mar; 39(5):332-40. PubMed ID: 8704064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men.
    Demiralay C; Jahn H; Kellner M; Yassouridis A; Wiedemann K
    Psychoneuroendocrinology; 2010 Nov; 35(10):1438-45. PubMed ID: 20554120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
    Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R
    J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin regulates human sleep by reducing rapid-eye-movement sleep.
    Born J; Kellner C; Uthgenannt D; Kern W; Fehm HL
    Am J Physiol; 1992 Mar; 262(3 Pt 1):E295-300. PubMed ID: 1550223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men.
    Rubin RT; Sekula LK; O'Toole S; Rhodes ME; Czambel RK
    Neuropsychopharmacology; 1999 May; 20(5):434-46. PubMed ID: 10192824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women.
    Kluge M; Gazea M; Schüssler P; Genzel L; Dresler M; Kleyer S; Uhr M; Yassouridis A; Steiger A
    Psychoneuroendocrinology; 2010 Feb; 35(2):297-304. PubMed ID: 19647945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
    Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
    Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.
    Sonntag A; Rothe B; Guldner J; Yassouridis A; Holsboer F; Steiger A
    Depression; 1996; 4(1):1-13. PubMed ID: 9160649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol enhances non-REM sleep and growth hormone secretion in elderly subjects.
    Bohlhalter S; Murck H; Holsboer F; Steiger A
    Neurobiol Aging; 1997; 18(4):423-9. PubMed ID: 9330974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep and signs of attention during 3 months of intranasal vasopressin: a pilot study in two elderly subjects.
    Perras B; Mölle M; Born J; Fehm HL
    Peptides; 1996; 17(7):1253-5. PubMed ID: 8959764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans.
    Dodt C; Pietrowsky R; Sewing A; Zabel A; Fehm HL; Born J
    J Gerontol; 1994 Jul; 49(4):M183-8. PubMed ID: 8014393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.